Mikael Hietala is an Impact Associate at Feelsgood, a Croatian impact-focused venture fund supporting startups in Croatia and Slovenia that address one or more of the 17 UN Sustainable Development Goals (SDGs).

French VC Partech closed its inaugural Partech Impact Fund, securing €300 million in total commitments to scale European B2B tech transforming global value chains.

BioInnovation Institute (BII), a non-profit foundation incubating and accelerating world-class innovation, announced that eleven new companies entered its Venture Lab acceleration program.

Emerald Technology Ventures, a globally recognized venture capital firm with two decades of water-sector leadership, announced reaching the €100 million milestone for its Global Water Fund II.

Daniel Uusitalo is an investor at 4impact capital, a venture fund backing Pre-seed to Series A startups in Europe that solve problems relating to Planet & People.

Amatera, a Paris-based biotechnology company, announced the closing of its latest funding round of €6 million in equity. The round was co-led by Demea Sustainable Investment (ex-Demeter) and Oyster Bay Venture Capital, with participation from existing investors - PINC, Mudcake, and Exceptional Ventures.

Antiverse, UK-based biotech developing AI-designed therapeutic antibodies for undruggable disease targets, closed a Series A round of $9.3 million. The round was led by Soulmates Ventures with participation from Innovation Investment Capital, DOMiNO Ventures and existing investors DBW, Kadmos Capital and i&i Biotech Fund.